 |
|
Familial Aggregation of Alzheimer Disease Among Whites, African Americans, and Caribbean Hispanics in Northern Manhattan
Gayatri Devi, MD;
Ruth Ottman, PhD;
Ming-Xin Tang, PhD;
Karen Marder, MD, MPH;
Yaakov Stern, PhD;
Richard Mayeux, MD, MSc
Arch Neurol. 2000;57:72-77.
Background Alzheimer disease (AD) aggregates in families.
Objective To compare the familial aggregation and lifetime risk of AD to the age of 90 years in the first-degree relatives of patients with AD and unrelated controls among Caribbean Hispanics, African Americans, and whites in Washington Heights, Manhattan, New York, NY.
Methods Family history of AD and demographic information were obtained from informants of 435 patients with probable or possible AD concerning 1577 siblings and parents and from 1094 controls without dementia concerning 3952 siblings and parents.
Results Lifetime risk of AD to the age of 90 years was 25.9% in relatives of patients and 19.1% in relatives of controls. Rate ratio (RR) for AD in relatives of patients compared with relatives of controls was 1.5 overall (95% confidence interval [CI], 1.2-1.9), and was greater for siblings (RR, 1.8; 95% CI, 1.2-2.5) than for parents (RR, 1.2; 95% CI, 0.9-1.8). Within ethnic groups, RR for AD among relatives was significantly elevated in whites (RR, 2.0; 95% CI, 1.2-3.3) and Hispanics (RR, 1.5; 95% CI, 1.1-2.1), but the difference did not reach statistical significance in African Americans (RR, 1.4; 95% CI, 0.7-2.7). Risk of AD was greater among relatives who were women compared with men (RR, 1.5; 95% CI, 1.2-1.9).
Conclusions Familial aggregation of AD was increased among families of patients compared with those of controls in all 3 ethnic groups. Risk of AD was highest among siblings and women relatives.
From the Gertrude H. Sergievsky Center (Drs Devi, Ottman, Tang, Marder, Stern, and Mayeux), Department of Neurology, College of Physicians and Surgeons (Drs Devi, Tang, Marder, Stern, and Mayeux), Taub Center for Alzheimer's Disease Research (Drs Devi, Tang, Marder, Stern, and Mayeux), School of Public Health (Epidemiology Division), Columbia University (Drs Ottman and Mayeux), and New York State Psychiatric Institute (Drs Ottman, Stern, and Mayeux), New York, NY.
RELATED ARTICLES
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(1):142-143.
FULL TEXT
Familial Risk for Alzheimer Disease in Ethnic Minorities: Nondiscriminating Genes
Lindsay A. Farrer
Arch Neurol. 2000;57(1):28-29.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Sensory Gating in Patients With Alzheimer's Disease and Their Biological Children
Ally et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;21:439-447.
ABSTRACT
Familial risk for Alzheimer's disease alters fMRI activation patterns
Bassett et al.
Brain 2006;129:1229-1239.
ABSTRACT
| FULL TEXT
Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease
Levy et al.
Arch Neurol 2004;61:1033-1039.
ABSTRACT
| FULL TEXT
Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects
Graff-Radford et al.
Arch Neurol 2002;59:594-600.
ABSTRACT
| FULL TEXT
Risk of Dementia Among White and African American Relatives of Patients With Alzheimer Disease
Green et al.
JAMA 2002;287:329-336.
ABSTRACT
| FULL TEXT
Intercontinental Epidemiology of Alzheimer Disease: A Global Approach to Bad Gene Hunting
Farrer
JAMA 2001;285:796-798.
FULL TEXT
Familial Risk for Alzheimer Disease in Ethnic Minorities: Nondiscriminating Genes
Farrer
Arch Neurol 2000;57:28-29.
FULL TEXT
|
